Ignite Creation Date:
2025-12-24 @ 9:09 PM
Ignite Modification Date:
2025-12-29 @ 7:55 PM
Study NCT ID:
NCT06333704
Status:
RECRUITING
Last Update Posted:
2025-03-19
First Post:
2024-03-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Post-marketing Surveillance (PMS) Use-Result Surveillance With SPIKEVAX BIVALENT and SPIKEVAX X Injection.
Sponsor:
ModernaTX, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-03-10
Start Date Type:
ACTUAL
Primary Completion Date:
2028-12-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-12-10
Completion Date Type:
ESTIMATED
First Submit Date:
2024-03-20
First Submit QC Date:
None
Study First Post Date:
2024-03-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-17
Last Update Post Date:
2025-03-19
Last Update Post Date Type:
ACTUAL